Healthcare Archives - Page 4 of 8

Héctor Pérez Montoyo, of Ability Pharma discusses his research on, “ABTL0812, a new immunotherapeutic anticancer agent at phase 2b clinical stage.”

June 3, 2021August 25, 2021 MarketsandMarkets Conferences

Héctor’s work has always focused on understanding the molecular pathophysiological mechanisms leading to autoimmunity and cancer development, investigating mechanism of action of newly developed molecules to treat such diseases. He started his career in 2006 when he moved to UT Southwestern Medical Center in Dallas (EEUU), to carry out this thesis in developing novel therapeutic antibodies in murine models of human autoimmune diseases. After obtaining his Ph.D., he combined two postdoctoral grants in Barcelona (Metastasis and Transformation group in Bellvitge Biomedical Research Center) and in Valencia (Autoimmune Pathology Lab in…

Dr. William Williams of Briacell Therapeutics Corporation talks about Personalized, off-the-shelf cellular immunotherapy for cancer

May 24, 2021 MarketsandMarkets Conferences

Dr. Williams is the President and CEO of BriaCell Corporation, where he has shepherded Bria-IMT™ into the clinic, established positive proof-of-concept, forged a collaboration with Incyte for novel combinations and coordinated the development of an off-the-shelf personalized approach to cancer immunotherapy. While at Incyte Corporation as Head of Exploratory Development, he brought numerous molecules into the clinic and established proof of concept in several disease areas. At GlaxoSmithKline he worked to bring several molecules into the clinic, ran a biomarker laboratory and spearheaded initiatives to utilize emerging technologies in drug…

Discussing Top 10 Disruptions in BioPharma Manufacturing at the MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT!

February 26, 2021 MarketsandMarkets Conferences

February 26th – MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT on the March 11, 2021 will hostindustry giants Fresenius Kabi, Charles River Laboratories, GenScript ProBio, Pall Corporation and MilliporeSigma to present their thoughts on the Top 10 Disruptions Through BioPharma Manufacturing in the next 5 year! MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT will gather 100+ professionals from industry giants such as Biocon Biologics, Ology Bioservices, Celonic AG, Gyroscope Therapeutics, GenIbet, Hemobras, H2i Group, MilliporeSigma, Orange Grove Bio, HORIBA, Porex Life Sciences Institute, Kaneka, Lonza, Cytiva, GEA North America, Batavia Biosciences, Nova…

Discussing “Laboratory miniaturization hand in hand with Microfabrication and Nanotechnology – systems integration at the microscale “with Dr. Vania Silverio of INESC-MN, Portugal.

February 22, 2021 MarketsandMarkets Conferences

Dr. Vania Silverio is a Microfluidics architect with strong background in microengineering. She combines know-how in simulation, design and fabrication of micron-sized fluidic paths with the integration of sensing and actuation elements towards the miniaturization of laboratories. Dr. Silverio is the Leader of the Microfluidics group at INESC Microsystems and Nanotechnologies (INESC MN) providing modular microfluidic solutions. She is Invited Assistant Professor at the Physics Department of Instituto Superior Tecnico (IST), ULisboa where, among others, she is the responsible for the curricular course on Microfluidics, unique in Portugal. She supervises…

Nicola Hodges from Royal United Hospitals Bath NHS Foundation, speaks about “Application of Point-Of-Care in disease outbreak”

February 10, 2021 MarketsandMarkets Conferences

Nicola is the POCT coordinator at the Royal United Hospitals Bath Foundation Trust and have been for just over 2 years now. She has been a senior biomedical scientist in biochemistry in the manual section again for around 2 years before this and a specialist BMS since 2003. Her most recent education was the certificate in expert practice in POCT awarded by the IBMS in 2021. She has always had a great passion for POCT, and she enjoys her job despite the many challenges. She believes that POCT is the…

Linda Krebs, & Allison Krebs-Bensch, of BeBe & Bella, LLC talk about V-Bella Homeopathic Boric Acid and Probiotic blend vaginal suppositories.

February 1, 2021 MarketsandMarkets Conferences

Linda and Allison have had a lifelong commitment to wellbeing and overall health. Living in the sunny South, they understand that proper skincare is an essential aspect of everyday life. In 2013 they became business partners creating the groundbreaking probiotic based skin care company – BeBe & Bella, LLC. Allison Krebs-Bensch, CEO of US Pharmaceutical Corporation, CEO and Co-Founder of BeBe & Bella, LLC followed her father in his original profession as a scientific innovator. As a trailblazer, Allison is always pushing to formulate products around new scientific discoveries. It…

Discussing ‘Reducing Errors at Point-Of-Care’ with Uchenna Okeahiala of Airedale and Bradford Hospitals Integrated Pathology Solutions, UK .

January 19, 2021 MarketsandMarkets Conferences

Graduated from University of Nigeria with a bachelor’s degree in Biomedical Sciences in 1989, Uchenna started her career as a Biomedical Scientist in Nigeria She relocated to the United Kingdom in 1991 where she obtained her Master’s degree in Biomedical Sciences from University of Cardiff with a Distinction in 1996 and went on to score a certificate in management from the Open University (1999). Later in 2006, she obtained a certificate in Extended Practice in Quality Management with Institute of Biomedical Sciences (IBMS). Since then has worked in various NHS…

Jyoti Chandok from Concordia University, Canada speaks about ‘Factors leading to the increase in demand POCT tech and challenges in upholding Quality Standards.’

January 14, 2021 MarketsandMarkets Conferences

Jyoti Chandok is a seasoned professional who has been working in the healthcare sector for over 19 years. She has fulfilled several roles specializing in patient care including phlebotomy, blood analysis for hematology, immunology, genetics, and specialized method development for HIV drug-level testing using mass spectrometry. Currently, Jyoti is an Assistant Chief Medical Technologist of Point-of-Care at the McGill University Health Center (MUHC) in Montreal, Quebec, Canada. She holds a B.Sc. in Cell and Molecular Biology from Concordia University and is an active member of both the Ordre professionnel des…

Julie Schwedock from Takeda Pharmaceuticals speaks about LBPs: What to consider when choosing CDMOs.

January 11, 2021 MarketsandMarkets Conferences

Julie Schwedock, PhD is Associate Director of the Microbial Development Team at Takeda Pharmaceuticals. She leads a cross-functional Pharmaceutical Sciences team for Live Bacterial Products (LBPs) focused on treating dysbiosis of the gut microbiome. She also heads a functional line group that works on process development for microbial expression systems as well as LPBs. Prior to that she was Associate Director of Analytical Development and QC at Vedanta Biosciences, also working with LBPs, where she developed analytics in an uncertain regulatory landscape for a product now in Ph2 clinical trials. …

Discussing combination strategies, pre-clinical and translational immune-oncology developments at the 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress

September 7, 2020September 7, 2020 MarketsandMarkets Conferences

September 7th – The 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress to be held on 29th – 30th October 2020 (British Standard Time) would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress will gather 20+ sponsors, 30+ leading industry speakers and 200+ professional. The 2-day event…